The global market demand of plasma-fractionated products is constantly increasing day by day. Besides growth in the magnitude of the market demand, there has been a visible advancement in the processes that ensure the quality and safety of products along with a better use of chromatography in fractionation technologies and changes in the patterns of clinical usage for the various plasma-fractionated products.
The primary drivers of plasma fractionation market processes have changed with time as new plasma products have been increasingly adopted and used across the globe. Also, the commercial availability of these products has increased with time.
Industry experts predict that due to increasing demand of plasma-fractionated products, the market for plasma collection will outpace overall blood collection through 2018. And the key market drivers for this speculation will be plasma-derived immunoglobulins (Ig) used to produce intravenous immunoglobulin (IVIG) therapies. According to expert research reports, ten times as much plasma is collected in the United States as in Europe- in 2013, 29.4 million liters to 2.3 million liters. So, in general, the increasing number of hemophilic patients, increasing use of albumin and immunoglobulin in various chronic diseases and growing prophylactic treatment are some of the important factors driving the plasma fractionation industry. Due to some of these key factors, plasma fractionation industry is expected to grow at a CAGR of 8.9% during the period of 2014 to 2019.
A well researched report on plasma fractionation market for 2016 to 2021 is now available with eMarketOrg.com. This research not just provides a basic overview of the industry including definitions, classifications, industry chain structure and applications; it also provides an expert market analysis for the international markets including competitive landscape analysis, development trends, and key regions development position. Company profiles are scrutinized providing their product picture, specification and more. Finally the probability of new investment projects are assessed and overall research conclusions offered.
Major players in the plasma fractionation market discussed in the report are Baxter , CSL, Grifols , Octapharma, BPL, Kedrion, RAAS , Mitsubishi Tanabe , CBOP and Hualan Bio. Read more at http://emarketorg.com/pro/global-plasma-fractionation-market-report-2016/ .